New hope for transplant patients fighting a dangerous virus
NCT ID NCT03216967
Summary
This study tested if switching to a different immune-suppressing drug (everolimus) helps kidney transplant patients clear a common and dangerous virus (BK virus) from their blood. It compared this switch to the standard approach of just lowering their current immune-suppressing drugs. The goal was to find a safer, more effective way to control the virus and protect the new kidney.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BK VIRUS NEPHROPATHY AFTER KIDNEY TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HP - Hôpital Georges Pompidou
Paris, 75908, France
-
AP-HP Hôpital Necker
Paris, 75743, France
-
CHRU - Hôpital Bretonneau
Tours, 37044, France
-
CHRU d'Angers
Angers, 49033, France
-
CHU - Hôpital Dupuytren
Limoges, 87042, France
-
CHU - Hôpital Maison Blanche
Reims, 51092, France
-
CHU - Hôpital Sud
Amiens, 80054, France
-
CHU - Hôpital de la Cavale Blanche
Bois-Guillaume, 76230, France
-
CHU - Hôpital de la Cavale Blanche
Brest, 29609, France
-
CHU Côte de Nacre
Caen, 14033, France
-
CHU Hôpital Gabriel Montpied
Clermont-Ferrand, 63000, France
-
CHU Poitiers - Hôpital Jean Bernard
Poitiers, 86021, France
-
CHU Rennes - Hôpital Pontchaillou
Rennes, 35033, France
-
Hôpital Edouard Herriot
Lyon, 69003, France
-
Les Hôpitaux Universitaires
Strasbourg, 67000, France
Conditions
Explore the condition pages connected to this study.